Chemoinformaics analysis of 2-Methylisoborneol
| Molecular Weight | 168.28 | nRot | 0 |
| Heavy Atom Molecular Weight | 148.12 | nRig | 18 |
| Exact Molecular Weight | 168.151 | nRing | 2 |
| Solubility: LogS | -4.307 | nHRing | 0 |
| Solubility: LogP | 3.753 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.5079 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.724 |
| Synth | 4.322 |
| Natural Product Likeliness | 1.441 |
| NR-PPAR-gamma | 0.988 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.498 |
| Pgp-sub | 0.762 |
| HIA | 0.012 |
| CACO-2 | -4.948 |
| MDCK | 0.0000284 |
| BBB | 0.088 |
| PPB | 0.972428 |
| VDSS | 1.093 |
| FU | 0.0434785 |
| CYP1A2-inh | 0.65 |
| CYP1A2-sub | 0.356 |
| CYP2c19-inh | 0.107 |
| CYP2c19-sub | 0.584 |
| CYP2c9-inh | 0.49 |
| CYP2c9-sub | 0.899 |
| CYP2d6-inh | 0.234 |
| CYP2d6-sub | 0.178 |
| CYP3a4-inh | 0.469 |
| CYP3a4-sub | 0.587 |
| CL | 12.753 |
| T12 | 0.874 |
| hERG | 0.007 |
| Ames | 0.282 |
| ROA | 0.241 |
| SkinSen | 0.833 |
| Carcinogencity | 0.658 |
| EI | 0.759 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.512 |
| Antiviral | No |
| Prediction | 0.804391 |